PURPOSE: Multidrug resistance (MDR) remains a major obstacle to successful chemotherapeutic treatment of cancer. Several chemotherapeutic and radiopharmaceutical agents are substrates of the pumps encoded by the MDR genes, and therefore, their accumulation is prevented. We evaluated in vivo whether [(99m)Tc]tetrofosmin ((99m)Tc-TF) uptake is influenced by the MDR profile of gliomas. PROCEDURES: Eighteen patients with histologically confirmed glioma were included in the study. Brain single-photon emission computed tomography by (99m)Tc-TF was performed within a week prior to surgical excision, and the expression of MRP5 was assessed by immunohistochemistry. Radiotracer accumulation was assessed by a semiquantitative method, calculating the lesion-to-normal uptake ratio. RESULTS: Using Spearman's ρ analysis, we found no correlation between tracer uptake expressed as lesion-to-normal and MRP5 expression. There was a significant correlation between glioma aggressiveness as assessed by Ki-67/MIB-1 and MRP5 expression. CONCLUSION: The present data suggest that (99m)Tc-TF uptake is not influenced by glioma's MDR phenotype. Thus, (99m)Tc-TF constitutes a suitable radiotracer for imaging gliomas.
PURPOSE: Multidrug resistance (MDR) remains a major obstacle to successful chemotherapeutic treatment of cancer. Several chemotherapeutic and radiopharmaceutical agents are substrates of the pumps encoded by the MDR genes, and therefore, their accumulation is prevented. We evaluated in vivo whether [(99m)Tc]tetrofosmin ((99m)Tc-TF) uptake is influenced by the MDR profile of gliomas. PROCEDURES: Eighteen patients with histologically confirmed glioma were included in the study. Brain single-photon emission computed tomography by (99m)Tc-TF was performed within a week prior to surgical excision, and the expression of MRP5 was assessed by immunohistochemistry. Radiotracer accumulation was assessed by a semiquantitative method, calculating the lesion-to-normal uptake ratio. RESULTS: Using Spearman's ρ analysis, we found no correlation between tracer uptake expressed as lesion-to-normal and MRP5 expression. There was a significant correlation between glioma aggressiveness as assessed by Ki-67/MIB-1 and MRP5 expression. CONCLUSION: The present data suggest that (99m)Tc-TF uptake is not influenced by glioma's MDR phenotype. Thus, (99m)Tc-TF constitutes a suitable radiotracer for imaging gliomas.
Authors: K Yokogami; H Kawano; T Moriyama; H Uehara; T Sameshima; T Oku; T Goya; S Wakisaka; S Nagamachi; S Jinnouchi; S Tamura Journal: Eur J Nucl Med Date: 1998-04
Authors: C Calatozzolo; M Gelati; E Ciusani; F L Sciacca; B Pollo; L Cajola; C Marras; A Silvani; L Vitellaro-Zuccarello; D Croci; A Boiardi; A Salmaggi Journal: J Neurooncol Date: 2005-09 Impact factor: 4.130
Authors: Andreas D Fotopoulos; George A Alexiou; Ann Goussia; Athanasios Papadopoulos; Athanasios P Kyritsis; Konstantinos S Polyzoidis; Spyridon Voulgaris; Spyridon Tsiouris Journal: J Neurooncol Date: 2008-05-06 Impact factor: 4.130
Authors: George A Alexiou; Andreas D Fotopoulos; Spyridon Tsiouris; Spyridon Voulgaris; Athanasios P Kyritsis Journal: Eur J Nucl Med Mol Imaging Date: 2010-09-07 Impact factor: 9.236
Authors: George A Alexiou; Andreas D Fotopoulos; Spyridon Tsiouris; Spyridon Voulgaris; Athanasios P Kyritsis Journal: J Neurooncol Date: 2010-12-28 Impact factor: 4.130
Authors: George A Alexiou; Xanthi Xourgia; Evrysthenis Vartholomatos; Spyridon Tsiouris; John A Kalef-Ezra; Andreas D Fotopoulos; Athanasios P Kyritsis Journal: Int J Mol Imaging Date: 2014-11-10